Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0S4OH
|
||||
Former ID |
DIB000101
|
||||
Drug Name |
Anti-CD20 engineered toxin bodies
|
||||
Synonyms |
Anti-CD20 engineered toxin bodies (lymphoma); Anti-CD20 ETBs (lymphoma), Molecular Templates; Anti-CD20 engineered toxin bodies (lymphoma), Molecular Templates
|
||||
Indication | Lymphoma [ICD9: 202.8, 208.9; ICD10:C81-C86] | Investigative | [543668] | ||
Company |
Molecular Templates Inc
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD20 | Target Info | Modulator | [543668] | |
KEGG Pathway | Hematopoietic cell lineage | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.